Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB1772 Latest Draft

Bill / Introduced Version Filed 01/17/2024

                             
 
 
Req. No. 2981 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 59th Legislature (2024) 
 
SENATE BILL 1772 	By: Hicks 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to public health; establishing the 
Oklahoma Rare Disease Advisory Council ; stating 
purpose and activities of the Council; providing 
appointment procedures and membership requirements; 
requiring submission of certain annual report; 
specifying duration of membership terms; providing 
for filling of vacancies; defining term; providing 
for codification; and providing an effective date. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 1-451 of Title 63, unless there 
is created a duplication in numberin g, reads as follows: 
A.  The Oklahoma Rare Disease Advisory Council shall be 
established within the State Department of Health in accordance with 
this section. 
B.  The purpose of the Council shall be to provide guidance and 
recommendations to educate the public, the Legislature , and other 
state agencies, as appropriate, on the needs of individuals with 
rare diseases living in this state.   
 
 
Req. No. 2981 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
C.  The Council shall conduct the following activities to 
benefit those impacted by rare diseases in this state: 
1.  Convene public hearings, make inquiries, and solicit 
comments from the general public in Oklahoma to assist the Council 
with a first-year landscape or survey of the needs of rare disease 
patients, caregivers, and providers in the state ; 
2.  Provide testimony and comments on pending legislation and 
regulations before the Legislature , if called, and other state 
agencies that impact Oklahoma ’s rare disease community ; 
3.  Consult with experts on rare diseases to develop policy 
recommendations to improve patient acc ess to, and quality of, rare 
disease specialists, affordable and comprehensive health care 
coverage, relevant diagnostics, timely treatment, and other needed 
services; 
4.  Establish best practices and proto cols to include in state 
planning related to natural disasters, public health emergencies, or 
other emergency declarations to enable continuity of care for rare 
disease patients and ensure safeguards against discrimination for 
rare disease patients are in place ; 
5.  Identify areas of unmet need for resear ch and opportunities 
for collaboration across stakeholders and other state rare disease 
advisory councils that can inform future studies and work done by 
the Council; and   
 
 
Req. No. 2981 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
6.  Research and identify best prac tices to reduce health 
disparities and achieve health equity in the research, diagnosis , 
and treatment of rare disease in this state. 
D.  1.  The Council’s appointment process shall be conducted in 
a transparent manner to provide interested individuals an 
opportunity to apply for membership on the Council.  All members of 
the Council shall be full -time residents of this state as 
practicable.  Membership shall include a diverse set of stakeholders 
representative of the geographic and population diversity of the 
state. 
2.  The Governor shall appoint the chair of the Council not 
later than December 1, 2024 .  The chair shall not hold any position 
within the government of this state. 
3.  The Chair shall appoint no fewer than seventeen (17) 
members, including the following : 
a. one representative of an academic research institution 
in the state that receives any grant funding for rare 
disease research, 
b. one representative of the State Department of Health ’s 
Office of Minority Health and Health Equity or 
successor division, 
c. one representative of the Oklahoma Health Care 
Authority, 
d. one representative of the Insurance Department,   
 
 
Req. No. 2981 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
e. one Registered Nurse or Advanced Practice Registered 
Nurse licensed and practicing in this state with 
experience treating rare diseases , 
f. one physician practicing in this state with experience 
treating rare diseases , 
g. one geneticist or genetic counselor , 
h. one hospital administrator, or his or her designee, 
from a hospital in this state that provides care to 
persons diagnosed with a rare disease, 
i. at least two patients who hav e a rare disease, 
j. at least one caregiver of a person w ith a rare 
disease, 
k. one representative of a rare disease patient 
organization that operates in this state, 
l. one pharmacist with experience dispensing drugs used 
to treat rare diseases, 
m. one representative of the biopharma ceutical industry, 
n. one representative of a health plan company , 
o. one member of the scientific community who is engaged 
in rare disease research including, but not limited 
to, a medical researcher with experience conducting 
research on rare diseases , and 
p. one mental health prov ider with experience t reating 
rare disease patients in this state.   
 
 
Req. No. 2981 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
E. 1. The Council shall electronically submit a report to the 
President Pro Tempore of the Senate, the Speaker of the House of 
Representatives, and the Governor within one year of establishment 
of the Oklahoma Rare Disease Advisory Council and annually 
thereafter.  Prior to submission, a draft of t he annual report shall 
be made available for public comment and d iscussed at an open pu blic 
meeting. 
2.  Annual reports shall: 
a. describe the activities and p rogress of the Council 
under this section, and 
b. provide recommendations to the Legislature and 
Governor on ways to address the needs of people living 
with rare diseases in this state. 
F.  1.  The initial meeting of the Council shall occur no later 
than February 1, 202 5. Thereafter, the Council shall meet no less 
than quarterly. 
2.  The Council shall: 
a. provide opportunities for the public to hear updates 
and provide input into its work, and 
b. create and maintain a public website where meeting 
minutes, notices of upcoming meetings, and public 
comments may be submitted. 
G.  1.  The Governor shall appoint the chair for an initial term 
of three (3) years.  At the end of the chair’s initial three-year   
 
 
Req. No. 2981 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
term, and every two (2) years thereafter, members of the Council 
shall elect, by a majority vote, a new chair. 
2.  Council members shall serve no longer than three (3) years, 
except that, to facilitate a staggered rotation of members to reta in 
continuity and knowledge transfer, during the initial five (5) years 
after the establishment of the Council, members may serve up to a 
four-year term. 
3.  If a vacancy occurs, the Council, by a majority vote, shall 
fill such vacancy in a time ly manner and in compliance with 
requirements set forth in subsection D of this section . 
H.  As used in this section, “rare disease”, sometimes called an 
orphan disease, means a disease that affects fewer than two hundred 
thousand (200,000) people in the United States. 
SECTION 2.  This act shall become effective November 1, 2024 . 
 
59-2-2981 DC 1/17/2024 12:31:31 PM